Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs Tencent Music Entertainment Group - ADR (TME) Price & Performance

Novartis AGTrade
Tencent Music Entertainment Group - ADRTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Tencent Music Entertainment Group - ADR — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Tencent Music Entertainment Group - ADR trades at $9.16 (market cap $15.08B). The key difference: Novartis AG is far larger — about 19.2× Tencent Music Entertainment Group - ADR's market cap, and Novartis AG pays the higher dividend (3.17%). Which is the better fit depends on your goals.

NVSTME
Market Cap
$290.25B$15.08B
Sector
HealthMedia
52-Week High
$168.62$26.36
52-Week Low
$113.50$8.16
Enterprise Value
$330.27B$11.85B
Dividend Yield
3.17%2.62%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About Tencent Music Entertainment Group - ADR

TME is the largest online music service provider in China. It was founded in 2016 with the business combination of QQ Music (founded in 2005), Kuwo Music (founded in 2005) and Kugou Music (founded in 2004) streaming platforms. Tencent is the largest shareholder of TME with over 50% shares and over 90% voting rights held. TME also provides social entertainment services, including music live audio/video broadcasts and online concert services through the three platforms mentioned above, and online karaoke through an independent platform WeSing.

Read more on TME